Please login to the form below

Not currently logged in
Email:
Password:

licensing

This page shows the latest licensing news and features for those working in and with pharma, biotech and healthcare.

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck hasn’t traditionally been a particularly active player in M&A, preferring to rely mainly on its in-house R&D and smaller-scale licensing deals, but has stepped up

Latest news

More from news
Approximately 10 fully matching, plus 586 partially matching documents found.

Latest Intelligence

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    Just Treatment is also urging the UK government to override Vertex’s patent via compulsory licensing or Crown Use Licence.

  • The Orkambi row explained The Orkambi row explained

    It has called for a Crown Use compulsory licensing of Orkambi, but this always looked like an outside bet. ... It urges the government to use Crown use compulsory licensing to gain access to cheaper versions of Orkambi.

  • #OrkambiNow? #OrkambiNow?

    UK government to issue a compulsory licensing of Orkambi. ... For example in Germany, from the time of European licensing, adults and children of 12 and over were able to access Orkambi if they had the right mutations.”.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Successful projects may then be considered for licensing to industrial partners to facilitate the progression of novel treatments into the clinic.

  • The UK’s new five-year pricing agreement The UK’s new five-year pricing agreement

    Scheme operation. Continued support for innovative medicines in the first three years post-licensing, including freedom of list pricing for new active substances and immediate line extensions.

More from intelligence
Approximately 5 fully matching, plus 89 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics